読み込み中…
掲載中の 596 社、うち 361 社が評価済み
ここに並ぶすべての企業が、同じ 5 つの成長・現金創出チェックを受けています。これは業種が今日報告している姿の説明であって、どれを買うべきかではありません。
| VRTX | VERTEX PHARMACEUTICALS INC / MA | B+ | $133.5B | $526.82 | 30.68 | $12.6B | 35.0% |
| MRNA | Moderna, Inc. | D- | $81.2B | $203.44 | — | $2.2B | -141.4% |
| REGN | REGENERON PHARMACEUTICALS, INC. | C+ | $80.1B | $750.43 | 18.54 | $15.5B | 27.9% |
| LGVN | LONGEVERON INC. | F- | $76.2B | $2.71 | — | $1.2M | -1,977.6% |
| ARGX | ARGENX SE | 評価なし | $60.1B | $970.42 | 49.59 | — | — |
| RVMD | Revolution Medicines, Inc. | F | $43.8B | $204.57 | — | $0.00 | — |
| ONC | BEONE MEDICINES LTD. | A+ | $41.6B | $365.49 | 65.38 | $6.1B | 10.7% |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | A+ | $34B | $254.04 | 128.95 | $3.7B | 19.7% |
| RPRX | Royalty Pharma plc | B+ | $32.4B | $58.22 | 30.97 | $2.5B | 32.1% |
| NCNA | NUCANA PLC | 評価なし | $26.6B | $1.28 | — | — | — |
| ROIV | ROIVANT SCIENCES LTD. | F- | $26.4B | $36.51 | — | $7.5M | -3,535.0% |
| INSM | INSMED INC | C- | $25.3B | $115.65 | — | $1.1B | -76.9% |
| BNTX | BioNTech SE | D | $24.8B | $98.54 | — | $3B | -42.9% |
| INCY | INCYTE CORPORATION | A+ | $24.6B | $123.25 | 17.41 | $5.4B | 26.7% |
| AKTX | Akari Therapeutics, Plc | 評価なし | $15.4B | $9.86 | — | — | — |
| JAZZ | Jazz Pharmaceuticals plc | A+ | $15.1B | $232.46 | 15.89 | $4.6B | 20.4% |
| EXEL | Exelixis Inc | A+ | $14.5B | $58.66 | 18.45 | $2.4B | 35.3% |
| ASND | Ascendis Pharma A/S | D | $14.1B | $228.11 | — | $1.2B | -21.8% |
| SMMT | Summit Therapeutics Inc. | F | $13.1B | $16.37 | — | $0.00 | — |
| BBIO | BridgeBio Pharma, Inc. | B | $12.9B | $65.94 | — | $713.1M | -98.5% |
| HALO | HALOZYME THERAPEUTICS, INC. | A+ | $12.7B | $111.54 | 32.52 | $1.7B | 24.9% |
| CORT | CORCEPT THERAPEUTICS INC | C | $12.4B | $114.79 | 273.31 | $830.8M | 6.6% |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | C- | $11.8B | $508.58 | — | $1.3B | -25.3% |
| TWST | Twist Bioscience Corporation | C- | $11.7B | $186.06 | — | $431.8M | -31.7% |
| BMRN | BIOMARIN PHARMACEUTICAL INC | A | $11.6B | $59.90 | 161.89 | $3.4B | 2.1% |
| TECH | BIO-TECHNE Corp | B+ | $11.3B | $72.37 | 62.93 | $1.2B | 15.0% |
| KRYS | Krystal Biotech, Inc. | A+ | $9.9B | $334.94 | 41.97 | $440.5M | 54.8% |
| AXSM | AXSOME THERAPEUTICS, INC. | B- | $9.7B | $185.93 | — | $776.6M | -24.7% |
| IBRX | IMMUNITYBIO, INC. | B | $9.4B | $8.83 | — | $165.8M | -598.6% |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | D- | $9.4B | $66.21 | — | $669.5M | -47.8% |
| KYMR | KYMERA THERAPEUTICS, INC. | D- | $9.2B | $110.56 | — | $105M | -285.3% |
| CYTK | CYTOKINETICS, INCORPORATED | F | $9.1B | $65.67 | — | $67.7M | -1,321.1% |
| PTGX | Protagonist Therapeutics, Inc | A+ | $9.1B | $140.93 | 138.17 | $282M | 29.4% |
| CAI | CARIS LIFE SCIENCES, INC. | A+ | $8.9B | $31.56 | 18.67 | $989.6M | 10.6% |
| TGTX | TG THERAPEUTICS, INC. | A+ | $8.6B | $56.19 | 20.43 | $799.5M | 55.2% |
| PCVX | VAXCYTE, INC. | 評価なし | $8.4B | $56.71 | — | — | — |
| PRAX | PRAXIS PRECISION MEDICINES, INC. | F | $7.9B | $281.36 | — | $0.00 | — |
| ABVX | Abivax S.A. | 評価なし | $7.7B | $98.50 | — | — | — |
| IONS | Ionis Pharmaceuticals, Inc. | F- | $7.6B | $45.91 | — | $874.1M | -64.7% |
| SYRE | SPYRE THERAPEUTICS, INC. | F | $7.5B | $84.70 | — | $0.00 | — |
| GPCR | Structure Therapeutics Inc. | 評価なし | $7B | $32.66 | — | — | — |
| IMVT | IMMUNOVANT, INC. | 評価なし | $6.9B | $33.45 | — | — | — |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | C- | $6.6B | $95.72 | — | $239.9M | -85.6% |
| BLTE | Belite Bio, Inc | 評価なし | $6.5B | $166.47 | — | — | — |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | B- | $6.5B | $14.45 | — | $325M | -89.1% |
| CGON | CG Oncology, Inc. | D- | $6.3B | $70.56 | — | $6.2M | -3,602.7% |
| LGND | LIGAND PHARMACEUTICALS INCORPORATED | A+ | $6.2B | $310.37 | 32.98 | $290.5M | 67.9% |
| SRRK | SCHOLAR ROCK HOLDING CORPORATION | F | $5.8B | $47.73 | — | $0.00 | — |
| KOD | KODIAK SCIENCES INC. | 評価なし | $5.7B | $91.15 | — | — | — |
| MIRM | Mirum Pharmaceuticals, Inc. | D- | $5.7B | $87.58 | — | $618.1M | -139.2% |
| GOSS | GOSSAMER BIO, INC. | B | $5.7B | $11.61 | — | $53.3M | -235.0% |
| TVTX | TRAVERE THERAPEUTICS, INC. | D- | $5.7B | $60.01 | — | $591.3M | -7.4% |
| COGT | Cogent Biosciences, Inc. | 評価なし | $5.5B | $31.66 | — | — | — |
| ORKA | Oruka Therapeutics, Inc. | 評価なし | $5.4B | $82.11 | — | — | — |
| PTCT | PTC Therapeutics, Inc. | D | $5.4B | $64.96 | — | $1B | -3.8% |
| CRSP | CRISPR THERAPEUTICS AG | F- | $5.4B | $56.03 | — | $13.4M | -3,368.7% |
| DFTX | Definium Therapeutics, Inc. | 評価なし | $5.1B | $38.22 | — | — | — |
| ERAS | Erasca, Inc. | 評価なし | $5B | $14.22 | — | — | — |
| MANE | Veradermics, Inc | 評価なし | $4.9B | $117.80 | — | — | — |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | F- | $4.9B | $87.18 | — | $2M | -9,442.3% |
| ABCL | AbCellera Biologics Inc. | D- | $4.5B | $14.83 | — | $66.2M | -248.8% |
| EWTX | Edgewise Therapeutics, Inc. | 評価なし | $4.3B | $39.19 | — | — | — |
| TNGX | Tango Therapeutics, Inc. | F- | $4.1B | $24.45 | — | $53.8M | -229.9% |
| RLAY | Relay Therapeutics, Inc. | C- | $4B | $18.38 | — | $10.4M | -2,763.6% |
| TLX | Telix Pharmaceuticals Limited | D- | $3.8B | $11.34 | — | $803.8M | -0.9% |
| CELC | CELCUITY INC. | 評価なし | $3.8B | $77.30 | — | — | — |
| VKTX | Viking Therapeutics, Inc. | F | $3.7B | $31.81 | — | $0.00 | — |
| IDYA | IDEAYA Biosciences, Inc. | D- | $3.6B | $37.82 | — | $234.1M | -74.8% |
| XENE | XENON PHARMACEUTICALS INC. | F | $3.6B | $37.27 | — | $0.00 | — |
| ACAD | ACADIA PHARMACEUTICALS INC. | A+ | $3.5B | $20.22 | 9.07 | $1.1B | 33.4% |
| LEGN | Legend Biotech Corp | C- | $3.5B | $18.81 | — | $1B | -24.6% |
| DBVT | DBV Technologies S.A. | F- | $3.4B | $11.57 | — | $5M | -3,506.5% |
| ELVN | ENLIVEN THERAPEUTICS, INC. | 評価なし | $3.4B | $46.51 | — | — | — |
| TARS | TARSUS PHARMACEUTICALS, INC. | A | $3.4B | $76.79 | — | $606.3M | -7.7% |
| ARQT | ARCUTIS BIOTHERAPEUTICS, INC. | A | $3.4B | $26.74 | 127.33 | $464M | 6.1% |
| DNLI | Denali Therapeutics Inc. | F- | $3.3B | $20.82 | — | $3.6M | -14,191.2% |
| RCUS | Arcus Biosciences, Inc. | D- | $3.3B | $25.64 | — | $117M | -393.2% |
| DYN | Dyne Therapeutics, Inc. | 評価なし | $3B | $16.22 | — | — | — |
| PGEN | PRECIGEN, INC. | F- | $2.9B | $8.06 | — | $9.7M | -1,628.5% |
| NAMS | NewAmsterdam Pharma Company N.V. | F- | $2.8B | $23.82 | — | $7.1M | -3,644.2% |
| MBX | MBX Biosciences, Inc. | 評価なし | $2.8B | $57.78 | — | — | — |
| BEAM | Beam Therapeutics Inc. | C- | $2.5B | $24.51 | — | $156M | -54.7% |
| IRON | Disc Medicine, Inc. | 評価なし | $2.5B | $65.89 | — | — | — |
| IMNM | Immunome, Inc. | F | $2.5B | $21.88 | — | $0.00 | — |
| CLDX | Celldex Therapeutics, Inc. | F- | $2.5B | $31.62 | — | $158K | -190,220.9% |
| NRIX | NURIX THERAPEUTICS, INC. | F- | $2.5B | $23.69 | — | $36.8M | -928.4% |
| VERA | Vera Therapeutics, Inc. | 評価なし | $2.3B | $32.38 | — | — | — |
| SLS | SELLAS Life Sciences Group, Inc. | 評価なし | $2.3B | $11.51 | — | — | — |
| HRMY | HARMONY BIOSCIENCES HOLDINGS, INC. | A+ | $2.3B | $39.28 | 12.71 | $959.9M | 18.9% |
| VRDN | Viridian Therapeutics, Inc./DE | D- | $2.3B | $20.00 | — | $71.1M | -544.1% |
| ADMA | ADMA BIOLOGICS, INC. | A+ | $2.2B | $9.97 | 14.24 | $512.3M | 33.0% |
| GMAB | Genmab A/S | A+ | $2.2B | $35.57 | 2.31 | $3.7B | 25.9% |
| AUPH | Aurinia Pharmaceuticals Inc. | A+ | $2.2B | $16.43 | 7.17 | $311.5M | 100.8% |
| MLYS | MINERALYS THERAPEUTICS, INC. | 評価なし | $2.2B | $24.44 | — | — | — |
| RXRX | RECURSION PHARMACEUTICALS, INC. | D- | $2.2B | $4.03 | — | $54.9M | -945.9% |
| VCEL | VERICEL CORPORATION | A | $2.1B | $40.63 | 86.44 | $306.3M | 7.9% |
| PHVS | Pharvaris N.V. | 評価なし | $2.1B | $31.71 | — | — | — |
| TRVI | Trevi Therapeutics, Inc. | 評価なし | $2.1B | $14.42 | — | — | — |
| NKTR | Nektar Therapeutics | F- | $2B | $59.31 | — | $54.6M | -287.8% |
| BHVN | Biohaven Ltd. | 評価なし | $2B | $13.30 | — | — | — |
| PVLA | Palvella Therapeutics, Inc. | 評価なし | $2B | $139.07 | — | — | — |
| AGIO | AGIOS PHARMACEUTICALS, INC. | C- | $2B | $33.30 | — | $98.3M | -418.2% |
| GENB | Generate Biomedicines, Inc. | 評価なし | $2B | $15.42 | — | — | — |
| URGN | UroGen Pharma Ltd. | C | $2B | $40.44 | — | $188.7M | -51.7% |
| NUVB | Nuvation Bio Inc. | C- | $2B | $5.62 | — | $169.9M | -88.2% |
| SRPT | SAREPTA THERAPEUTICS, INC. | B- | $2B | $18.65 | — | $2B | -6.9% |
| LKFT | GALAPAGOS NV | B | $1.9B | $29.56 | 5.34 | $1.3B | 28.9% |
| MESO | MESOBLAST LIMITED | C- | $1.9B | $14.89 | — | $65.4M | -156.2% |
| ZYME | ZYMEWORKS INC. | F- | $1.9B | $27.14 | — | $37.1M | -404.0% |
| FTRE | FORTREA HOLDINGS INC. | C | $1.9B | $19.76 | — | $2.7B | -3.2% |
| XNCR | Xencor, Inc | F- | $1.9B | $24.99 | — | $105M | -155.6% |
| SEPN | Septerna, Inc. | B | $1.8B | $39.11 | — | $98.9M | -24.5% |
| VIR | Vir Biotechnology, Inc. | C- | $1.8B | $10.66 | — | $303.2M | -83.0% |
| NVAX | NOVAVAX INC | D | $1.8B | $10.83 | — | $413.8M | -59.9% |
| ZBIO | Zenas BioPharma, Inc. | F- | $1.7B | $26.74 | — | $10M | -4,843.8% |
| ABSI | ABSCI CORP | F- | $1.7B | $10.13 | — | $1.6M | -7,756.4% |
| OCUL | OCULAR THERAPEUTIX, INC | F- | $1.7B | $7.86 | — | $52.1M | -579.1% |
| NTLA | INTELLIA THERAPEUTICS, INC. | C- | $1.7B | $12.04 | — | $59.5M | -672.2% |
| STOK | Stoke Therapeutics, Inc. | F- | $1.7B | $25.90 | — | $27.6M | -753.6% |
| TSHA | Taysha Gene Therapies, Inc. | F- | $1.6B | $5.00 | — | $5.5M | -2,728.0% |
| SNDX | Syndax Pharmaceuticals, Inc. | D- | $1.6B | $18.24 | — | $252.3M | -87.5% |
| RAPP | Rapport Therapeutics, Inc. | 評価なし | $1.6B | $33.07 | — | — | — |
| IMCR | Immunocore Holdings plc | C- | $1.6B | $30.76 | — | $430.8M | -4.2% |
| QURE | uniQure N.V. | C- | $1.5B | $24.51 | — | $18.1M | -1,154.4% |
| INBX | INHIBRX BIOSCIENCES, INC. | D- | $1.5B | $104.83 | — | $1.3M | -10,629.3% |
| GHRS | GH Research PLC | 評価なし | $1.5B | $24.70 | — | — | — |
| NBTX | Nanobiotix S.A. | C- | $1.5B | $31.59 | — | $37.1M | -73.5% |
| INVA | INNOVIVA, INC. | B+ | $1.5B | $21.12 | 5.14 | $440M | 81.2% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC. | C | $1.5B | $15.32 | — | $717.2M | -81.7% |
| ANAB | ANAPTYSBIO, INC. | B+ | $1.5B | $50.32 | 8.77 | $237.6M | 82.4% |
| MAZE | MAZE THERAPEUTICS, INC. | F- | $1.5B | $27.02 | — | $167.5M | -79.8% |
| AVBP | ARRIVENT BIOPHARMA, INC. | 評価なし | $1.5B | $29.54 | — | — | — |
| OMER | OMEROS CORP | 評価なし | $1.4B | $19.27 | 11.20 | — | — |
| AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | F- | $1.4B | $14.86 | — | $85.6M | -216.5% |
| ORIC | ORIC PHARMACEUTICALS, INC. | 評価なし | $1.4B | $13.35 | — | — | — |
| DRTS | Alpha Tau Medical Ltd. | 評価なし | $1.3B | $15.20 | — | — | — |
| TYRA | Tyra Biosciences, Inc. | 評価なし | $1.3B | $21.98 | — | — | — |
| TRAX | FIRST TRACKS BIOTHERAPEUTICS, INC. | 評価なし | $1.3B | $35.97 | — | — | — |
| DMRA | DAMORA THERAPEUTICS, INC. | 評価なし | $1.3B | $20.65 | — | — | — |
| BCAX | Bicara Therapeutics Inc. | 評価なし | $1.2B | $18.54 | — | — | — |
| REPL | REPLIMUNE GROUP, INC. | 評価なし | $1.2B | $12.99 | — | — | — |
| LBRX | LB Pharmaceuticals Inc | 評価なし | $1.2B | $37.23 | — | — | — |
| IMTX | Immatics N.V. | 評価なし | $1.1B | $8.56 | — | — | — |
| MRVI | Maravai LifeSciences Holdings, Inc. | D- | $1.1B | $7.65 | — | $208.8M | -37.1% |
| VOR | Vor Biopharma Inc. | 評価なし | $1.1B | $18.33 | 0.10 | — | — |
| MNKD | MANNKIND CORP | C | $1.1B | $3.34 | — | $393.6M | -11.1% |
| MGTX | MeiraGTx Holdings plc | A | $1.1B | $11.13 | 15.67 | $397.5M | 19.9% |
| SVRA | Savara Inc | 評価なし | $1B | $5.10 | — | — | — |
| ANRO | Alto Neuroscience, Inc. | 評価なし | $1B | $26.58 | — | — | — |
| JANX | Janux Therapeutics, Inc. | B- | $1B | $16.95 | — | $24M | -427.5% |
| AKTS | Aktis Oncology, Inc. | 評価なし | $1B | $19.72 | — | — | — |
| FDMT | 4D Molecular Therapeutics, Inc. | C- | $1B | $14.50 | — | $92M | -194.7% |
| GLUE | Monte Rosa Therapeutics, Inc. | D- | $1B | $11.75 | — | $28.7M | -560.8% |
| APMD | Apnimed, Inc. | 評価なし | $996.6M | $23.94 | — | — | — |
| CRVS | Corvus Pharmaceuticals, Inc. | 評価なし | $986.7M | $11.73 | — | — | — |
| CGEM | CULLINAN THERAPEUTICS, INC. | 評価なし | $980.8M | $15.24 | — | — | — |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 評価なし | $973.6M | $11.44 | — | — | — |
| KURA | KURA ONCOLOGY, INC. | D- | $960.8M | $10.80 | — | $77.2M | -384.3% |
| ABUS | Arbutus Biopharma Corp | C+ | $926.9M | $4.69 | 5.93 | $181.7M | 84.2% |
| ALMS | Alumis Inc. | D- | $920M | $7.28 | — | $7.4M | -5,933.5% |
| RIGL | RIGEL PHARMACEUTICALS, INC. | B+ | $913.1M | $48.88 | 2.90 | $276.8M | 116.3% |
| JAGX | JAGUAR HEALTH, INC. | B | $906.4M | $5.29 | — | $27.8M | -132.2% |
| JBIO | Jade Biosciences, Inc. | 評価なし | $903.1M | $14.20 | — | — | — |
| TBPH | Theravance Biopharma, Inc. | B | $884.2M | $17.03 | 16.86 | $104.3M | 51.6% |
| SANA | Sana Biotechnology, Inc. | 評価なし | $874.1M | $2.92 | — | — | — |
| SGP | SpyGlass Pharma, Inc. | 評価なし | $851.3M | $25.45 | — | — | — |
| ARDX | ARDELYX, INC. | B- | $843.5M | $3.39 | — | $450.9M | -12.4% |
| LXRX | LEXICON PHARMACEUTICALS, INC. | C- | $838.7M | $1.89 | — | $41.5M | -147.4% |
| AVTX | AVALO THERAPEUTICS, INC. | F- | $834.2M | $15.56 | — | $59K | -170,055.9% |
| CADL | CANDEL THERAPEUTICS, INC. | 評価なし | $832.5M | $10.88 | — | — | — |
| ANNX | ANNEXON, INC. | 評価なし | $819.1M | $4.15 | — | — | — |
| GYRE | Gyre Therapeutics, Inc. | D- | $817.4M | $7.33 | — | $119.4M | -23.6% |
| GERN | GERON CORP | 評価なし | $796.7M | $1.24 | — | — | — |
| ACHV | Achieve Life Sciences, Inc. | 評価なし | $791.8M | $7.70 | — | — | — |
| DSGN | Design Therapeutics, Inc. | F | $791M | $12.64 | — | $0.00 | — |
| ACRS | Aclaris Therapeutics, Inc. | D- | $777.2M | $5.28 | — | $8.2M | -921.5% |
| SLDB | Solid Biosciences Inc. | 評価なし | $768.8M | $7.17 | — | — | — |
| IMMX | IMMIX BIOPHARMA, INC. | 評価なし | $752.6M | $10.52 | — | — | — |
| OLMA | OLEMA PHARMACEUTICALS, INC. | 評価なし | $748.1M | $8.55 | — | — | — |
| VSTM | Verastem, Inc. | D- | $716.4M | $7.91 | — | $87.5M | -231.6% |
| WVE | WAVE LIFE SCIENCES LTD. | F- | $715.3M | $3.63 | — | $42.7M | -473.9% |
| PHAR | Pharming Group N.V. | A | $714M | $10.18 | 254.38 | $376.1M | 0.8% |
| OABI | OMNIAB, INC. | D- | $689.2M | $4.74 | — | $38.5M | -115.1% |
| IMMP | Immutep Limited | D- | $683.5M | $4.68 | — | $7.3M | -594.6% |
| MDXG | MiMedx Group, Inc. | C | $680.7M | $4.67 | 116.75 | $355.2M | 1.8% |
| ZVRA | Zevra Therapeutics, Inc. | A+ | $672.8M | $11.33 | 12.32 | $136.1M | 42.8% |
| NVCT | Nuvectis Pharma, Inc. | 評価なし | $669.9M | $20.56 | — | — | — |
| DNA | GINKGO BIOWORKS HOLDINGS, INC. | D- | $663.8M | $11.97 | — | $111.9M | -260.0% |
| CLYM | CLIMB BIO, INC. | 評価なし | $661.7M | $11.52 | — | — | — |
| STTK | Shattuck Labs, Inc. | C- | $656.4M | $6.54 | — | $1M | -5,256.8% |
| AURA | Aura Biosciences, Inc. | 評価なし | $638.3M | $6.16 | — | — | — |
| IVA | Inventiva S.A. | F | $636.7M | $3.30 | — | $5.1M | -7,899.6% |
| CRMD | CORMEDIX INC. | A+ | $618.9M | $7.94 | 3.87 | $462.2M | 40.5% |
| IBO | Impact BioMedical, INC. | A | $600M | $5.57 | 6.32 | $35K | 2,254.3% |
| CTMX | CytomX Therapeutics, Inc. | F- | $597M | $2.74 | — | $18.3M | -435.2% |
| PHAT | PHATHOM PHARMACEUTICALS, INC. | B | $596.6M | $7.38 | — | $239.7M | -41.3% |
| ALT | ALTIMMUNE, INC. | D- | $575.8M | $2.96 | — | $41K | -223,804.9% |
| NGNE | Neurogene Inc. | F | $568.3M | $28.40 | — | $0.00 | — |
| PRME | Prime Medicine, Inc. | C- | $564.1M | $3.11 | — | $4.6M | -4,056.4% |
| ALLO | Allogene Therapeutics, Inc. | B- | $558M | $1.62 | — | $6.8M | -2,419.5% |
| CBIO | CRESCENT BIOPHARMA, INC. | D- | $548.6M | $14.77 | — | $10.8M | -885.5% |
| YDES | YD Bio Limited | D | $547.9M | $7.74 | — | $596.8K | -1,392.6% |
| MNPR | Monopar Therapeutics Inc. | F | $537.1M | $80.02 | — | $0.00 | — |
| VALN | Valneva SE | D- | $534.9M | $6.17 | — | $177.9M | -73.7% |
| COAG | Hemab Therapeutics Holdings, Inc. | 評価なし | $509.9M | $32.67 | — | — | — |
| SLN | Silence Therapeutics plc | C- | $509.3M | $10.78 | — | $615K | -9,748.5% |
| CNTN | CANTON STRATEGIC HOLDINGS, INC. | 評価なし | $507.4M | $2.39 | — | — | — |
| PBYI | PUMA BIOTECHNOLOGY, INC. | B+ | $505.4M | $9.79 | 18.83 | $231.2M | 11.6% |
| ANL | Adlai Nortye Ltd. | C | $502.2M | $15.71 | — | $5M | -710.6% |
| CAPR | CAPRICOR THERAPEUTICS, INC. | F- | $498.3M | $8.57 | — | $0.00 | — |
| PBLS | Parabilis Medicines, Inc. | 評価なし | $496M | $31.89 | — | — | — |
| AUTL | Autolus Therapeutics plc | C- | $492.4M | $1.85 | — | $117.4M | -238.7% |
| RGNX | REGENXBIO Inc. | D- | $490.8M | $7.44 | — | $174.5M | -112.6% |
| ARVN | ARVINAS, INC. | B | $490.7M | $7.51 | 31.27 | $316.7M | 2.9% |
| OCS | Oculis Holding AG | 評価なし | $477.5M | $9.14 | — | — | — |
| ASMB | Assembly Biosciences, Inc. | B- | $477.5M | $23.45 | 22.99 | $72.3M | -0.1% |
| TECX | TECTONIC THERAPEUTIC, INC. | 評価なし | $455.1M | $23.28 | — | — | — |
| PRTA | PROTHENA CORPORATION PUBLIC LIMITED COMPANY | C- | $451M | $8.79 | — | $54.5M | -80.7% |
| AGEN | AGENUS INC | C | $444.8M | $9.88 | 3.83 | $132.7M | 69.3% |
| DMAC | DiaMedica Therapeutics Inc. | 評価なし | $443.3M | $8.22 | — | — | — |
| SPRY | ARS Pharmaceuticals, Inc. | D- | $438.6M | $4.41 | — | $116.9M | -184.2% |
| MPLT | MapLight Therapeutics, Inc. | 評価なし | $429.5M | $10.12 | — | — | — |
| EIKN | EIKON THERAPEUTICS, INC. | 評価なし | $429M | $7.92 | — | — | — |
| KYTX | Kyverna Therapeutics, Inc. | 評価なし | $423.6M | $6.85 | — | — | — |
| AVLN | Avalyn Pharma Inc. | 評価なし | $422M | $27.19 | — | — | — |
| AVIR | Atea Pharmaceuticals, Inc. | 評価なし | $413.9M | $5.16 | — | — | — |
| IRD | Opus Genetics, Inc. | F- | $411M | $4.94 | — | $9.9M | -1,091.8% |
| ODTX | Odyssey Therapeutics, Inc. | 評価なし | $405.4M | $22.48 | — | — | — |
| TTRX | Turn Therapeutics Inc. | 評価なし | $402.7M | $13.52 | — | — | — |
| SGMT | Sagimet Biosciences Inc. | 評価なし | $399.8M | $9.32 | — | — | — |
| EDIT | EDITAS MEDICINE, INC. | B- | $398.5M | $2.60 | — | $47M | -157.3% |
| RLMD | RELMADA THERAPEUTICS, INC. | 評価なし | $397.9M | $3.73 | — | — | — |
| RZLT | REZOLUTE, INC. | 評価なし | $395.6M | $4.09 | — | — | — |
| GALT | GALECTIN THERAPEUTICS INC. | 評価なし | $394.3M | $3.91 | — | — | — |
| ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC. | F- | $389.1M | $13.69 | — | $29.4M | -317.6% |
| CCCC | C4 Therapeutics, Inc. | C- | $383.8M | $3.12 | — | $35M | -289.4% |
| ZURA | ZURA BIO LIMITED | 評価なし | $383.3M | $4.00 | — | — | — |
| FENC | FENNEC PHARMACEUTICALS INC. | C- | $378M | $10.78 | — | $59.2M | -5.5% |
| SRZN | Surrozen, Inc./DE | D | $374.6M | $31.87 | — | $11.5M | -2,885.3% |
| OCGN | OCUGEN, INC. | C | $369.6M | $1.09 | — | $4.6M | -1,786.3% |
| ENTA | ENANTA PHARMACEUTICALS, INC | F- | $368.7M | $12.66 | — | $65.3M | -96.9% |
| OBIO | Orchestra BioMed Holdings, Inc. | F- | $365.7M | $6.09 | — | $32M | -184.6% |
| SPTX | Seaport Therapeutics, Inc. | 評価なし | $358.8M | $18.77 | — | — | — |
| ARTV | Artiva Biotherapeutics, Inc. | F- | $344.4M | $7.05 | — | $0.00 | — |
| DRUG | BRIGHT MINDS BIOSCIENCES INC. | 評価なし | $341.6M | $49.67 | — | — | — |
| BNTC | Benitec Biopharma Inc. | D | $340.5M | $9.76 | — | $0.00 | — |
| CABA | CABALETTA BIO, INC. | 評価なし | $336.5M | $1.99 | — | — | — |
| LRMR | LARIMAR THERAPEUTICS, INC. | 評価なし | $326.2M | $3.14 | — | — | — |
| IMUX | Immunic, Inc. | 評価なし | $325.1M | $8.94 | — | — | — |
| VERU | VERU INC. | 評価なし | $318.3M | $2.58 | — | — | — |
| PRLD | PRELUDE THERAPEUTICS INC | B- | $315.2M | $3.95 | — | $22.4M | -269.7% |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | 評価なし | $314.3M | $3.92 | — | — | — |
| GTBP | GT BIOPHARMA, INC. | 評価なし | $306.7M | $6.80 | 18.37 | — | — |
| VNDA | VANDA PHARMACEUTICALS INC. | F- | $303.5M | $5.02 | — | $215.7M | -127.4% |
| EVMN | Evommune, Inc. | D- | $302.3M | $8.33 | — | $10M | -946.7% |
| IPSC | Century Therapeutics, Inc. | B- | $298.8M | $1.65 | — | $109.2M | -100.6% |
| EPRX | EUPRAXIA PHARMACEUTICALS INC. | F | $295.8M | $8.30 | — | $0.00 | — |
| EYPT | EyePoint, Inc. | F- | $295.7M | $3.43 | — | $2.8M | -10,994.7% |
| ABEO | ABEONA THERAPEUTICS INC. | C- | $295.1M | $5.16 | — | $25.5M | -246.4% |
| SABS | SAB BIOTHERAPEUTICS, INC. | F- | $293.9M | $3.23 | — | $0.00 | — |
| KARD | Kardigan, Inc. | 評価なし | $292.4M | $14.70 | — | — | — |
| XFOR | X4 PHARMACEUTICALS, INC | D- | $288.5M | $2.91 | — | $15.8M | -568.8% |
| OBX | OBSIDIAN THERAPEUTICS, INC. | F | $287.1M | $14.54 | — | $0.00 | — |
| FATE | FATE THERAPEUTICS INC | D- | $285.2M | $2.38 | — | $6.5M | -1,941.1% |
| UPB | UPSTREAM BIO, INC. | D- | $284.8M | $5.20 | — | $3.2M | -4,955.7% |
| RCKT | Rocket Pharmaceuticals, Inc. | D | $284.3M | $2.59 | — | $0.00 | — |
| QTTB | Q32 Bio Inc. | B | $284M | $9.54 | 3.05 | $53.7M | 62.9% |
| IKT | Inhibikase Therapeutics, Inc. | F | $282.6M | $2.03 | — | $0.00 | — |
| FULC | FULCRUM THERAPEUTICS, INC. | F- | $282.3M | $3.70 | — | $0.00 | — |
| LXEO | Lexeo Therapeutics, Inc. | 評価なし | $280.6M | $3.42 | — | — | — |
| HELP | CYBIN INC. | 評価なし | $274.1M | $12.69 | — | — | — |
| GLSI | GREENWICH LIFESCIENCES, INC. | 評価なし | $271.3M | $18.48 | — | — | — |
| IMRX | Immuneering Corporation | 評価なし | $267.8M | $4.14 | — | — | — |
| STRO | SUTRO BIOPHARMA, INC. | F | $267.5M | $16.13 | — | $45.7M | -395.2% |
| LIMN | LIMINATUS PHARMA, INC. | 評価なし | $263.6M | $3.93 | — | — | — |
| ACIU | AC IMMUNE SA | F- | $263.5M | $2.59 | — | $4.3M | -1,207.8% |
| BCYC | Bicycle Therapeutics plc | D- | $255.3M | $3.66 | — | $61.2M | -311.1% |
| PALI | PALISADE BIO, INC. | C- | $251.8M | $1.45 | — | $500K | -6,388.2% |
| IVVD | INVIVYD, INC. | C- | $250.6M | $0.85 | — | $58.4M | -183.9% |
| CTNM | Contineum Therapeutics, Inc. | D | $250.4M | $10.84 | — | $0.00 | — |
| CAMP | CAMP4 Therapeutics Corporation | B- | $245.4M | $3.91 | — | $3.5M | -3,065.9% |
| TRDA | ENTRADA THERAPEUTICS, INC. | F- | $244.1M | $6.27 | — | $4.7M | -3,537.7% |
| LCTX | Lineage Cell Therapeutics, Inc. | D- | $242.7M | $0.96 | — | $13.1M | -246.6% |
| PYXS | Pyxis Oncology, Inc. | D- | $241.5M | $2.90 | — | $13.9M | -640.3% |
| MGNX | MACROGENICS, INC. | C- | $239.5M | $3.76 | — | $167.7M | -8.7% |
| LYEL | Lyell Immunopharma, Inc. | D- | $236M | $9.63 | — | $27K | -920,285.2% |
| SION | SIONNA THERAPEUTICS, INC. | 評価なし | $232.8M | $5.15 | — | — | — |
| ZLAB | ZAI LAB LIMITED | C- | $229.6M | $25.92 | — | $449.6M | -41.9% |
| KROS | Keros Therapeutics, Inc. | D- | $222.5M | $11.22 | — | $15M | -553.9% |
| CGEN | COMPUGEN LTD | B+ | $221.3M | $2.34 | 6.16 | $74M | 47.6% |
| AVXL | ANAVEX LIFE SCIENCES CORP. | 評価なし | $220.6M | $2.38 | — | — | — |
| RNAC | Cartesian Therapeutics, Inc. | F | $219M | $7.24 | — | $1.5M | -10,283.8% |
| PLX | Protalix BioTherapeutics, Inc. | A+ | $217.5M | $2.70 | 11.74 | $80.6M | 23.5% |
| MLEC | MOOLEC SCIENCE SA | D | $217.4M | $5.60 | — | $333.6M | -52.9% |
| WHWK | WHITEHAWK THERAPEUTICS, INC. | F | $213.2M | $3.74 | — | $0.00 | — |
| ALEC | Alector, Inc. | D- | $209.9M | $1.88 | — | $13.9M | -850.1% |
| FHTX | Foghorn Therapeutics Inc. | B | $208.4M | $3.51 | — | $36.7M | -175.8% |
| ELDN | Eledon Pharmaceuticals, Inc. | 評価なし | $204.4M | $2.52 | — | — | — |
| SLGL | Sol-Gel Technologies Ltd. | B | $200.8M | $72.08 | — | $1.8M | -341.3% |
| CMPX | COMPASS THERAPEUTICS, INC. | F | $196.3M | $1.09 | — | $0.00 | — |
| ORMP | ORAMED PHARMACEUTICALS INC. | C | $195.1M | $4.69 | 1.14 | $2M | 8,743.5% |
| ZNTL | Zentalis Pharmaceuticals, Inc. | F | $194.2M | $2.71 | — | $0.00 | — |
| ANTX | AN2 Therapeutics, Inc. | 評価なし | $192.5M | $5.10 | — | — | — |
| TARA | Protara Therapeutics, Inc. | 評価なし | $190.6M | $3.23 | — | — | — |
| ADAG | Adagene Inc. | C- | $189.8M | $3.21 | — | $7.7M | -229.6% |
| ACOG | Alpha Cognition Inc. | D- | $189.5M | $8.70 | — | $15.3M | -153.6% |
| NKTX | Nkarta, Inc. | D | $188.4M | $2.63 | — | $0.00 | — |
| CUE | Cue Biopharma, Inc. | D- | $186.3M | $25.64 | — | $37.7M | -435.8% |
| ALXO | ALX ONCOLOGY HOLDINGS INC | 評価なし | $185.3M | $1.34 | — | — | — |
| INDP | Indaptus Therapeutics, Inc. | 評価なし | $183.4M | $2.86 | — | — | — |
| CHRS | Coherus Oncology, Inc. | B | $183.1M | $1.19 | — | $50.9M | -259.4% |
| OVID | Ovid Therapeutics Inc. | C- | $180M | $2.54 | — | $1.6M | -2,178.9% |
| MDWD | MEDIWOUND LTD. | F- | $177M | $13.79 | — | $11.9M | -170.1% |
| PRQR | ProQR Therapeutics N.V. | C- | $174.4M | $1.66 | — | $20.9M | -229.7% |
| MOLN | MOLECULAR PARTNERS AG | F- | $173.6M | $4.30 | — | $5.2M | -1,437.4% |
| NAUT | Nautilus Biotechnology, Inc. | 評価なし | $173.1M | $1.36 | — | — | — |
| DTIL | PRECISION BIOSCIENCES INC | D- | $170.9M | $6.19 | — | $45.1M | -117.0% |
| TNXP | TONIX PHARMACEUTICALS HOLDING CORP. | D- | $165.9M | $9.67 | — | $29.1M | -548.6% |
| VYGR | Voyager Therapeutics, Inc. | F- | $162.7M | $2.64 | — | $34.5M | -312.6% |
| PEPG | PEPGEN INC. | 評価なし | $162.1M | $2.34 | — | — | — |
| ABOS | Acumen Pharmaceuticals, Inc. | 評価なし | $162M | $2.24 | — | — | — |
| NERV | Minerva Neurosciences, Inc. | F | $160.4M | $3.36 | — | $0.00 | — |
| KRSA | CYCLERION THERAPEUTICS, INC. | F- | $159.6M | $34.10 | — | $1.9M | -353.0% |
| BRVE | Braveheart Bio, Inc. | 評価なし | $159.6M | $22.38 | — | — | — |
| CURX | Curanex Pharmaceuticals Inc | 評価なし | $158.7M | $5.06 | — | — | — |
| NBP | NovaBridge Biosciences | 評価なし | $158.6M | $1.38 | — | — | — |
| NRSN | NeuroSense Therapeutics Ltd. | 評価なし | $154.3M | $4.74 | — | — | — |
| MENS | Jyong Biotech Ltd. | 評価なし | $153.6M | $2.02 | — | — | — |
| NGEN | NERVGEN PHARMA CORP. | 評価なし | $153.3M | $1.93 | — | — | — |
| IPHA | Innate Pharma SA | F- | $150.9M | $1.61 | — | $10.2M | -546.1% |
| CDXS | Codexis, Inc. | D- | $148.4M | $1.36 | — | $77.7M | -39.6% |
| HUMA | Humacyte, Inc. | C- | $148.3M | $0.53 | — | $2.1M | -4,560.8% |
| CLLS | Cellectis S.A. | C- | $147.4M | $1.47 | — | $72.9M | -92.7% |
| RANI | RANI THERAPEUTICS HOLDINGS, INC. | C- | $144.5M | $0.80 | — | $4.9M | -618.0% |
| RNA | Atrium Therapeutics, Inc. | 評価なし | $144M | $8.42 | — | — | — |
| KRRO | Korro Bio, Inc. | C- | $141.1M | $9.58 | — | $2.4M | -4,477.1% |
| SPRB | Spruce Biosciences, Inc. | F | $136.6M | $47.53 | — | $0.00 | — |
| TNYA | Tenaya Therapeutics, Inc. | 評価なし | $134.6M | $0.60 | — | — | — |
| IFRX | InflaRx N.V. | F- | $134.5M | $1.86 | — | $33.4K | -155,582.1% |
| CRBU | Caribou Biosciences, Inc. | D- | $133.5M | $1.25 | — | $10M | -1,030.4% |
| MSLE | Satellos Bioscience Inc. | 評価なし | $132.9M | $8.60 | — | — | — |
| ARMP | ARMATA PHARMACEUTICALS, INC. | 評価なし | $132.7M | $3.57 | — | — | — |
| VOGX | Vogenx, Inc. | 評価なし | $132.6M | $24.32 | — | — | — |
| HURA | TuHURA BIOSCIENCES, INC./NV | F | $131.6M | $2.07 | — | $0.00 | — |
| ENTX | ENTERA BIO LTD. | F | $131.6M | $2.68 | — | $0.00 | — |
| ENGN | enGene Therapeutics Inc. | 評価なし | $130.7M | $1.95 | — | — | — |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 評価なし | $127.7M | $6.60 | — | — | — |
| UNCY | UNICYCIVE THERAPEUTICS, INC. | 評価なし | $127.3M | $4.57 | — | — | — |
| NMRA | NEUMORA THERAPEUTICS, INC. | 評価なし | $127.3M | $0.68 | — | — | — |
| LENZ | LENZ THERAPEUTICS, INC. | D- | $121.6M | $3.87 | — | $19.1M | -660.1% |
| SEER | SEER, INC. | D- | $119M | $2.15 | — | $14.2M | -478.0% |
| COYA | Coya Therapeutics, Inc. | F- | $118.3M | $5.05 | — | $8M | -270.2% |
| AARD | AARDVARK THERAPEUTICS, INC. | F | $118M | $5.39 | — | $0.00 | — |
| INO | INOVIO PHARMACEUTICALS, INC. | D | $115.8M | $1.12 | — | $0.00 | — |
| TLSA | Tiziana Life Sciences Ltd | 評価なし | $115.7M | $0.96 | — | — | — |
| VANI | Vivani Medical, Inc. | F | $111.9M | $1.24 | — | $0.00 | — |
| GNLX | GENELUX CORPORATION | F- | $110.9M | $2.45 | — | $8K | -444,950.0% |
| BDTX | BLACK DIAMOND THERAPEUTICS, INC. | D | $108M | $1.88 | — | $0.00 | — |
| CNXU | CONEXEU SCIENCES INC. | 評価なし | $105.4M | $3.74 | — | — | — |
| OKUR | ONKURE THERAPEUTICS, INC. | C | $105.1M | $2.60 | — | $0.00 | — |
| QNCX | Quince Therapeutics, Inc. | 評価なし | $104.3M | $31.64 | — | — | — |
| PLYX | Polaryx Therapeutics, Inc. | 評価なし | $102.7M | $2.06 | — | — | — |
| EQ | EQUILLIUM, INC. | C- | $102.4M | $1.62 | — | $41.1M | -43.8% |
| MIST | Milestone Pharmaceuticals Inc. | 評価なし | $101.2M | $0.81 | — | — | — |
| PROK | ProKidney Corp. | F- | $100.6M | $1.64 | — | $818K | -10,288.4% |
| NTRB | NUTRIBAND INC. | F- | $98.8M | $8.13 | — | $1.6M | -430.4% |
| ANIX | ANIXA BIOSCIENCES, INC. | 評価なし | $98.7M | $2.84 | — | — | — |
| FTH | Faeth Therapeutics, Inc. | 評価なし | $97.9M | $28.11 | — | — | — |
| PMN | PROMIS NEUROSCIENCES INC. | 評価なし | $97.3M | $10.85 | — | — | — |
| NRXS | NEURAXIS, INC. | D- | $96.7M | $7.70 | — | $5.3M | -144.4% |
| PYPD | PolyPid Ltd | 評価なし | $95.4M | $5.24 | 2.51 | — | — |
| MNOV | MEDICINOVA, INC. | C- | $93.8M | $1.91 | — | $920.5K | -1,168.2% |
| BMEA | Biomea Fusion, Inc. | 評価なし | $91.7M | $1.27 | — | — | — |
| CRDF | CARDIFF ONCOLOGY, INC. | F- | $91.4M | $1.18 | — | $508K | -7,884.1% |
| CGTX | Cognition Therapeutics, Inc. | 評価なし | $90.5M | $0.95 | — | — | — |
| RLYB | RALLYBIO CORPORATION | D | $89.5M | $16.86 | 3.43 | $646K | 7,051.2% |
| ICCC | ImmuCell Corporation | A | $89.3M | $9.83 | 140.43 | $30.7M | 2.6% |
| ACRV | Acrivon Therapeutics, Inc. | 評価なし | $89.1M | $2.08 | — | — | — |
| ONCY | ONCOLYTICS BIOTECH INC. | 評価なし | $85.2M | $0.67 | — | — | — |
| NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | D | $84.8M | $3.27 | — | $40K | -118,029.5% |
| GUTS | Fractyl Health, Inc. | F- | $82.7M | $0.52 | — | $0.00 | — |
| PTHS | Pelthos Therapeutics Inc. | C- | $81.5M | $21.29 | — | $50.4M | -171.4% |
| FBIO | Fortress Biotech, Inc. | B | $81.4M | $2.20 | 0.83 | $68.5M | 163.3% |
| TELO | Telomir Pharmaceuticals, Inc. | 評価なし | $81.2M | $1.18 | — | — | — |
| ATRA | ATARA BIOTHERAPEUTICS, INC. | D | $81.1M | $8.08 | — | $6.2M | -269.4% |
| ALDX | ALDEYRA THERAPEUTICS, INC. | 評価なし | $79.6M | $1.32 | — | — | — |
| VRCA | Verrica Pharmaceuticals Inc. | C- | $77.3M | $4.50 | — | $30.3M | -102.8% |
| PMVP | PMV PHARMACEUTICALS, INC. | 評価なし | $77M | $1.44 | — | — | — |
| ATTO | Attovia Therapeutics, Inc. | 評価なし | $76M | $18.12 | — | — | — |
| IBIO | IBIO, INC. | D- | $75.6M | $1.18 | — | $100K | -33,044.0% |
| LONA | LeonaBio, Inc. | 評価なし | $75.5M | $3.53 | — | — | — |
| LEXX | LEXARIA BIOSCIENCE CORP. | D- | $74.9M | $3.02 | — | $194K | -3,985.6% |
| OSTX | OS THERAPIES INCORPORATED | 評価なし | $74.3M | $1.61 | — | — | — |
| GANX | GAIN THERAPEUTICS, INC | 評価なし | $73.8M | $1.69 | — | — | — |
| CING | Cingulate Inc. | 評価なし | $71.7M | $4.93 | — | — | — |
| OKYO | OKYO Pharma Limited | 評価なし | $71.4M | $1.36 | — | — | — |
| RNXT | RENOVORX, INC. | D- | $70.6M | $1.57 | — | $2M | -621.7% |
| MAIA | MAIA Biotechnology, Inc. | F | $69.9M | $1.15 | — | $0.00 | — |
| SPRO | Spero Therapeutics, Inc. | C | $69.9M | $1.20 | 8.57 | $47M | 15.7% |
| BSEM | BioStem Technologies, Inc. | D- | $69.2M | $3.88 | — | $34.6M | -81.8% |
| TENX | TENAX THERAPEUTICS, INC. | F | $69M | $1.85 | — | $0.00 | — |
| KLRS | KALARIS THERAPEUTICS, INC. | 評価なし | $69M | $2.90 | — | — | — |
| RNTX | Rein Therapeutics, Inc. | F | $68.5M | $0.79 | — | $0.00 | — |
| CSBR | CHAMPIONS ONCOLOGY, INC. | D- | $68.2M | $4.90 | — | $60.7M | -1.8% |
| PLRX | PLIANT THERAPEUTICS, INC. | D | $66.9M | $1.08 | — | $0.00 | — |
| XBIT | XBIOTECH INC. | 評価なし | $66.5M | $2.18 | — | — | — |
| ALPS | ALPS GROUP INC | 評価なし | $65.7M | $0.40 | — | — | — |
| HYFT | MindWalk Holdings Corp. | C- | $64.7M | $1.39 | — | $19.8M | -43.6% |
| LNAI | Lunai Bioworks Inc. | 評価なし | $64.2M | $1.77 | — | — | — |
| ACET | Adicet Bio, Inc. | 評価なし | $63.9M | $6.83 | — | — | — |
| CNTB | Connect Biopharma Holdings Limited | C- | $63M | $1.00 | — | $3M | -2,336.3% |
| INKT | MiNK Therapeutics, Inc. | 評価なし | $62.3M | $12.20 | — | — | — |
| HYPD | HYPERION DEFI, INC. | D+ | $62.1M | $4.00 | — | $1.4M | 474.9% |
| ELOX | ELOXX PHARMACEUTICALS, INC. | D | $61.4M | $15.21 | — | $0.00 | — |
| MREO | MEREO BIOPHARMA GROUP PLC | B | $59.5M | $0.37 | — | $500K | -5,619.8% |
| BRTX | BIORESTORATIVE THERAPIES, INC. | F- | $59.4M | $2.33 | — | $357.9K | -3,089.6% |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | C- | $58.6M | $0.31 | — | $151.2M | -22.5% |
| OTLK | OUTLOOK THERAPEUTICS, INC. | F+ | $58.4M | $0.63 | — | -$1.2M | 5,253.5% |
| BOLD | BOUNDLESS BIO, INC. | 評価なし | $58.2M | $2.56 | — | — | — |
| EXOZ | EXOZYMES INC. | 評価なし | $58M | $6.25 | — | — | — |
| ALGS | Aligos Therapeutics, Inc. | D- | $57.7M | $5.54 | — | $3.7M | -2,031.1% |
| BLSM | BlossomHill Therapeutics, Inc. | 評価なし | $56.9M | $21.48 | — | — | — |
| SCTX | SCRIBE THERAPEUTICS INC. | 評価なし | $56.8M | $23.01 | — | — | — |
| SKYE | Skye Bioscience, Inc. | 評価なし | $56.3M | $1.59 | — | — | — |
| BCAB | BIOATLA, INC. | 評価なし | $56.1M | $1.74 | — | — | — |
| ANVS | Annovis Bio, Inc. | F | $55.8M | $1.31 | — | $0.00 | — |
| INMB | INMUNE BIO INC. | D- | $54.4M | $1.96 | — | $50K | -36,832.0% |
| XLO | Xilio Therapeutics, Inc. | C- | $53.1M | $9.19 | — | $64.1M | -34.1% |
| CLNN | Clene Inc. | D | $52.7M | $4.11 | — | $197K | -20,059.9% |
| IMA | ImageneBio, Inc. | D- | $52.2M | $4.60 | — | $800K | -6,560.5% |
| SER | Serina Therapeutics, Inc. | D | $50.8M | $2.00 | — | $130K | -16,288.5% |
| CLGN | CollPlant Biotechnologies Ltd | B- | $50.2M | $3.92 | — | $2.4M | -484.6% |
| ELTX | Elicio Therapeutics, Inc. | 評価なし | $48.6M | $1.85 | — | — | — |
| TIL | Instil Bio, Inc. | C- | $48.5M | $7.16 | — | $9M | -337.7% |
| DWTX | Dogwood Therapeutics, Inc. | 評価なし | $45.6M | $1.34 | — | — | — |
| TVGN | Tevogen Inc. | 評価なし | $45.1M | $6.93 | — | — | — |
| FLNA | Filana Therapeutics, Inc. | 評価なし | $44.8M | $0.93 | — | — | — |
| GRCE | Grace Therapeutics, Inc. | 評価なし | $44.8M | $2.13 | — | — | — |
| CELU | Celularity Inc. | C | $44.6M | $1.38 | — | $19M | -374.7% |
| HOWL | WEREWOLF THERAPEUTICS, INC. | 評価なし | $44M | $0.91 | — | — | — |
| CRVO | CervoMed Inc. | F- | $43.5M | $2.88 | — | $331.3K | -9,160.9% |
| MGX | Metagenomi Therapeutics, Inc. | D- | $42.9M | $1.14 | — | $22.3M | -418.5% |
| LITS | Lite Strategy, Inc. | D | $41.8M | $1.38 | — | $0.00 | — |
| PDSB | PDS Biotechnology Corp | 評価なし | $41.4M | $0.74 | — | — | — |
| TCRX | TSCAN THERAPEUTICS, INC. | F- | $41.2M | $0.32 | — | $7.1M | -1,655.4% |
| KAPA | KAIROS PHARMA, LTD. | 評価なし | $39.8M | $1.68 | — | — | — |
| ATHE | ALTERITY THERAPEUTICS LTD | 評価なし | $38.4M | $3.61 | — | — | — |
| ICU | SeaStar Medical Holding Corp | D- | $36.8M | $3.69 | — | $1.7M | -795.5% |
| ATNM | ACTINIUM PHARMACEUTICALS, INC. | D+ | $36M | $1.15 | 3.18 | $90K | 12,564.4% |
| NIKI | Niki BioSolutions, Inc. | 評価なし | $35M | $4.76 | — | — | — |
| MCRB | Seres Therapeutics, Inc. | D- | $34.8M | $3.50 | — | $1.9M | -1,192.9% |
| EDSA | EDESA BIOTECH, INC. | 評価なし | $34.8M | $3.61 | — | — | — |
| NNVC | NANOVIRICIDES, INC. | F | $33.1M | $1.30 | — | $0.00 | — |
| BYSI | BeyondSpring Inc. | D | $31.8M | $0.77 | — | $0.00 | — |
| CVM | CEL-SCI CORPORATION | 評価なし | $31.1M | $1.77 | — | — | — |
| ATYR | aTYR PHARMA INC | F- | $30.2M | $0.31 | — | $190K | -32,003.7% |
| ELAB | PMGC HOLDINGS INC. | D- | $30M | $3.70 | — | $2.6M | -523.0% |
| CNTX | CONTEXT THERAPEUTICS INC. | 評価なし | $29.2M | $0.32 | — | — | — |
| IGC | IGC PHARMA, INC. | C- | $28M | $0.27 | — | $1.3M | -560.3% |
| ABVC | ABVC BioPharma, Inc. | D- | $28M | $1.05 | — | $296K | -2,400.9% |
| KYNB | KYNTRA BIO, INC. | F | $27.7M | $6.84 | 0.15 | $4.6M | 3,967.8% |
| EVAX | Evaxion A/S | B- | $27.3M | $3.27 | — | $7.5M | -102.4% |
| CALC | CalciMedica, Inc. | 評価なし | $26.3M | $1.60 | — | — | — |
| APRE | Aprea Therapeutics, Inc. | 評価なし | $26M | $0.76 | — | — | — |
| APLM | Apollomics Inc. | B | $25.8M | $23.40 | — | $8.5M | -128.7% |
| NRXP | NRX Pharmaceuticals, Inc. | B | $25.8M | $2.92 | — | $3.4M | -691.8% |
| ENLV | Enlivex Ltd. | 評価なし | $23.7M | $0.49 | 0.02 | — | — |
| GRDX | GRIDAI TECHNOLOGIES CORP | F- | $23.5M | $3.30 | — | $36.3K | -56,864.0% |
| NXTC | NEXTCURE, INC | 評価なし | $22.4M | $4.90 | — | — | — |
| COCP | COCRYSTAL PHARMA, INC. | 評価なし | $21.8M | $1.13 | — | — | — |
| YARW | YARROW BIOSCIENCE, INC. | C- | $20.6M | $23.97 | — | $570K | -4,646.1% |
| ESLA | ESTRELLA IMMUNOPHARMA, INC. | 評価なし | $20M | $0.46 | — | — | — |
| JSPR | JASPER THERAPEUTICS, INC. | 評価なし | $19.8M | $0.60 | — | — | — |
| ATOS | ATOSSA THERAPEUTICS, INC. | 評価なし | $19.7M | $1.97 | — | — | — |
| CNSP | CNS Pharmaceuticals, Inc. | 評価なし | $18.6M | $4.93 | — | — | — |
| MRKR | MARKER THERAPEUTICS, INC. | D- | $18.3M | $1.10 | — | $3.9M | -220.5% |
| MTNB | MATINAS BIOPHARMA HOLDINGS, INC. | 評価なし | $18.1M | $2.82 | — | — | — |
| LPCN | LIPOCINE INC. | C- | $17.7M | $2.15 | — | $1.6M | -755.1% |
| ACTU | Actuate Therapeutics, Inc. | 評価なし | $17.2M | $0.72 | — | — | — |
| TVRD | TVARDI THERAPEUTICS, INC. | C- | $17.2M | $1.29 | — | $7.6M | -344.2% |
| CLRB | Cellectar Biosciences, Inc. | 評価なし | $17.2M | $1.82 | — | — | — |
| DYAI | DYADIC INTERNATIONAL INC | F- | $17.1M | $0.47 | — | $3.8M | -200.5% |
| PTN | PALATIN TECHNOLOGIES, INC. | B- | $16.7M | $9.38 | — | $13.2M | -63.6% |
| LTGO | Latigo Biotherapeutics, Inc. | 評価なし | $16.7M | $18.10 | — | — | — |
| KTTA | PASITHEA THERAPEUTICS CORP. | 評価なし | $16.4M | $0.49 | — | — | — |
| BCTX | BRIACELL THERAPEUTICS CORP. | 評価なし | $16.1M | $4.08 | — | — | — |
| KZIA | Kazia Therapeutics Limited. | F | $15.8M | $9.78 | 8.68 | $29.3K | -54,287.3% |
| BCDA | BioCardia, Inc. | F | $15.6M | $1.03 | — | $0.00 | — |
| CTXR | Citius Pharmaceuticals, Inc. | 評価なし | $15.3M | $0.56 | — | — | — |
| PASG | PASSAGE BIO, INC. | 評価なし | $15M | $4.67 | — | — | — |
| CNSY | CERENOME, INC. | F- | $14.1M | $1.86 | — | $4.2M | -620.7% |
| HIND | VYOME HOLDINGS, INC. | F- | $14.1M | $2.01 | — | $129.7K | -8,716.8% |
| LTRN | Lantern Pharma Inc. | 評価なし | $13.9M | $1.09 | — | — | — |
| NCEL | NewcelX Ltd. | 評価なし | $13.7M | $2.87 | 1.33 | — | — |
| LSTA | LISATA THERAPEUTICS, INC. | C- | $13.1M | $1.46 | — | $100K | -14,621.0% |
| AEON | AEON Biopharma, Inc. | 評価なし | $13.1M | $0.26 | — | — | — |
| VTGN | VISTAGEN THERAPEUTICS, INC. | F- | $13M | $0.29 | — | $2.5M | -2,702.6% |
| PLUR | Pluri Inc. | D | $12.8M | $1.04 | — | $1M | -2,344.6% |
| INAB | IN8BIO, INC. | 評価なし | $12.8M | $1.30 | — | — | — |
| DARE | Dare Bioscience, Inc. | C- | $12.5M | $0.81 | — | $1.4M | -804.4% |
| RADX | Radiopharm Theranostics Limited | F- | $12.2M | $1.55 | — | $3.6M | -1,055.3% |
| TPST | Tempest Therapeutics, Inc. | 評価なし | $12.1M | $0.82 | — | — | — |
| KPRX | KIORA PHARMACEUTICALS, INC. | D | $11.8M | $2.67 | — | $0.00 | — |
| BIVI | BioVie Inc. | 評価なし | $11.6M | $1.54 | — | — | — |
| CMMB | SNOWDRIFT PARENT CORPORATION | 評価なし | $11.6M | $1.61 | 89.44 | — | — |
| BLRX | BioLineRx Ltd | C- | $11.3M | $2.60 | — | $1.2M | -171.7% |
| INTS | INTENSITY THERAPEUTICS, INC. | 評価なし | $11.2M | $3.43 | — | — | — |
| MTVA | METAVIA INC. | 評価なし | $11M | $1.67 | — | — | — |
| ADIL | Adial Pharmaceuticals, Inc. | 評価なし | $10.7M | $4.09 | — | — | — |
| MBRX | Moleculin Biotech, Inc. | D | $10.4M | $0.53 | — | $0.00 | — |
| KALA | KALA BIO, INC. | F | $9.8M | $0.51 | — | $0.00 | — |
| TOVX | Theriva Biologics, Inc. | 評価なし | $9.8M | $0.21 | — | — | — |
| GDTC | CytoMed Therapeutics Limited | D- | $9.8M | $0.83 | — | $253.9K | -1,227.1% |
| TRAW | Traws Pharma, Inc. | C- | $9.6M | $0.62 | — | $2.8M | -773.0% |
| SNTI | Senti Biosciences Holdings, Inc. | F- | $9.5M | $0.31 | — | $22K | -225,290.9% |
| IMRN | IMMURON LIMITED | D- | $9.5M | $1.18 | — | $5.1M | -71.6% |
| FBLG | FibroBiologics, Inc. | 評価なし | $8.9M | $1.33 | — | — | — |
| ALZN | ALZAMEND NEURO, INC. | 評価なし | $8.8M | $1.83 | — | — | — |
| VRAX | Virax Biolabs Group Ltd | C- | $8.2M | $2.20 | — | $6.3K | -95,739.2% |
| ENSC | ENSYSCE BIOSCIENCES, INC. | D- | $8.2M | $0.42 | — | $4.5M | -280.5% |
| SNGX | SOLIGENIX, INC. | D- | $7.8M | $0.36 | — | $119.4K | -8,577.8% |
| CBUS | Cibus, Inc. | C- | $7.8M | $1.56 | — | $4.3M | -2,258.9% |
| XCUR | EXICURE, INC. | F | $7.5M | $1.14 | — | $0.00 | — |
| IMNN | Imunon, Inc. | 評価なし | $7.4M | $1.32 | — | — | — |
| ALLR | Allarity Therapeutics, Inc. | B- | $7.4M | $0.97 | — | $320K | -3,854.4% |
| ARTL | ARTELO BIOSCIENCES, INC. | 評価なし | $7.2M | $4.15 | — | — | — |
| BOLT | Bolt Biotherapeutics, Inc. | D- | $6.9M | $3.58 | — | $4.7M | -611.5% |
| ACXP | Acurx Pharmaceuticals, Inc. | 評価なし | $6.9M | $1.31 | — | — | — |
| ENVB | ENVERIC BIOSCIENCES, INC. | 評価なし | $6.6M | $1.47 | — | — | — |
| CELZ | Creative Medical Technology Holdings, Inc. | D- | $6.2M | $0.95 | — | $3K | -201,355.4% |
| PULM | PULMATRIX, INC. | B- | $5.9M | $1.61 | — | $7.8M | -51.4% |
| AGMB | AgomAb Therapeutics NV | 評価なし | $5.7M | $10.46 | — | — | — |
| CDIO | Cardio Diagnostics Holdings, Inc. | C- | $5.6M | $1.90 | — | $14.5K | -44,771.8% |
| XBIO | XENETIC BIOSCIENCES, INC. | D- | $5.4M | $2.30 | — | $3.3M | -75.9% |
| ERNA | Ernexa Therapeutics Inc. | B- | $5.3M | $3.23 | — | $582K | -2,106.0% |
| XTLB | XTL BIOPHARMACEUTICALS LTD. | F | $5.2M | $2.20 | — | $451K | -1,545.2% |
| PCSA | Processa Pharmaceuticals, Inc. | 評価なし | $4.9M | $1.76 | — | — | — |
| SCNI | SCINAI IMMUNOTHERAPEUTICS LTD. | B- | $4.8M | $1.39 | — | $1.5M | -558.6% |
| PHIO | PHIO PHARMACEUTICALS CORP. | 評価なし | $4.7M | $1.03 | — | — | — |
| GRI | GRI BIO, INC. | 評価なし | $4.5M | $2.07 | — | — | — |
| PMCB | PHARMACYTE BIOTECH, INC. | D | $4.5M | $0.42 | — | $0.00 | — |
| DRMA | DERMATA THERAPEUTICS, INC. | 評価なし | $4.5M | $1.12 | — | — | — |
| QNTM | Quantum BioPharma Ltd. | 評価なし | $4.3M | $3.80 | — | — | — |
| SXTP | 60 DEGREES PHARMACEUTICALS, INC. | D- | $4.3M | $1.21 | — | $1.1M | -729.9% |
| OSRH | OSR HEALTH, INC. | D- | $4.1M | $0.12 | — | $1.8M | -824.4% |
| CVKD | Cadrenal Therapeutics, Inc. | 評価なし | $3.9M | $1.09 | — | — | — |
| EVGN | EVOGENE LTD. | D- | $3.5M | $0.41 | — | $1.3M | -649.2% |
| ADXN | Addex Therapeutics Ltd | D- | $3.5M | $2.81 | — | $36K | -22,448.4% |
| REVB | REVELATION BIOSCIENCES, INC. | 評価なし | $3.3M | $0.84 | — | — | — |
| APVO | Aptevo Therapeutics Inc. | 評価なし | $3.3M | $1.82 | — | — | — |
| HCWB | HCW Biologics Inc. | B- | $3.3M | $1.78 | — | $6.7M | -83.8% |
| MBIO | MUSTANG BIO, INC. | 評価なし | $3.2M | $0.48 | — | — | — |
| PBM | PSYENCE BIOMEDICAL LTD | 評価なし | $3M | $5.50 | — | — | — |
| HLSQ | BiomX Inc. | 評価なし | $2.8M | $0.43 | — | — | — |
| SILO | SILO PHARMA, INC. | F- | $2.6M | $1.63 | — | $54.1K | -8,269.5% |
| GOVX | GEOVAX LABS, INC. | D | $2.6M | $0.35 | — | $0.00 | — |
| TCRT | Alaunos Therapeutics, Inc. | D- | $2.5M | $0.97 | — | $3K | -133,666.7% |
| GNPX | Genprex, Inc. | D | $2.4M | $2.89 | — | $0.00 | — |
| AZTR | Azitra, Inc. | F- | $2.3M | $0.13 | — | $0.00 | — |
| VBIO | Valion Bio, Inc. | F- | $2.2M | $2.98 | — | $482K | -3,890.0% |
| OGEN | ORAGENICS, INC. | 評価なし | $2.2M | $0.49 | — | — | — |
| JUNS | JUPITER NEUROSCIENCES, INC. | F | $1.9M | $2.52 | — | $21.8K | -42,206.9% |
| AIM | AIM IMMUNOTECH INC. | D | $1.9M | $0.17 | — | $95K | -15,021.1% |
| CANF | Can-Fite BioPharma Ltd. | F- | $1.8M | $2.18 | — | $405K | -2,426.7% |
| SPRC | SCISPARC LTD. | F- | $1.8M | $4.84 | — | $856K | -1,422.8% |
| CRIS | CURIS, INC. | F- | $1.7M | $0.82 | — | $4.3M | -490.3% |
| RNAZ | TRANSCODE THERAPEUTICS, INC. | 評価なし | $1.6M | $1.67 | — | — | — |
| DCOY | Decoy Therapeutics Inc. | 評価なし | $1.4M | $2.11 | — | — | — |
| BBLG | BONE BIOLOGICS CORPORATION | 評価なし | $1.3M | $0.48 | — | — | — |
| VIVS | VivoSim Labs, Inc. | D | $1.1M | $0.21 | — | $112K | -11,016.1% |
| CLDI | Calidi Biotherapeutics, Inc. | 評価なし | $1.1M | $1.05 | — | — | — |
| LABT | Lakewood-Amedex Biotherapeutics Inc. | 評価なし | $1M | $0.98 | — | — | — |
| QNRX | Quoin Pharmaceuticals Ltd. | 評価なし | $997.3K | $5.68 | — | — | — |
| ONCO | Onconetix, Inc. | D- | $949K | $0.82 | — | $645.8K | -1,578.8% |
| CMND | Clearmind Medicine Inc. | 評価なし | $920.4K | $0.79 | — | — | — |
| PPCB | PROPANC BIOPHARMA, INC. | 評価なし | $586.2K | $0.52 | — | — | — |
| KLRA | Kailera Therapeutics, Inc. | 評価なし | $561.9K | $10.99 | — | — | — |
| PLRZ | Polyrizon Ltd. | 評価なし | $488.7K | $10.78 | 2.20 | — | — |
| CDT | CDT EQUITY INC. | 評価なし | $441.2K | $1.45 | — | — | — |
| EDVA | SPLASH BEVERAGE GROUP, INC. | D | $370.9K | $0.17 | — | $32.1K | -53,856.5% |
| BDRX | Biodexa Pharmaceuticals PLC | 評価なし | $369.2K | $0.67 | — | — | — |
| SLXN | SILEXION THERAPEUTICS CORP | 評価なし | $162.5K | $0.32 | — | — | — |
| NEUP | Neuphoria Therapeutics Inc. | F- | $108.2K | $3.60 | — | $1.2M | -1,145.7% |
| KPTI | Karyopharm Therapeutics Inc. | B | $30.7K | $1.21 | — | $146.6M | -153.3% |
| PPBT | PURPLE BIOTECH LTD. | 評価なし | $362.44 | $1.51 | — | — | — |
| ADRX | ADARx Pharmaceuticals, Inc. | 評価なし | — | $20.64 | — | — | — |
| APGE | Apogee Therapeutics, Inc. | 評価なし | — | $135.07 | — | — | — |
| ATAI | AtaiBeckley Inc. | 評価なし | — | $7.35 | — | $4.1M | -16,142.0% |
| BRNS | BARINTHUS BIOTHERAPEUTICS PLC | D- | — | $0.74 | — | $0.00 | — |
| CRNX | Crinetics Pharmaceuticals, Inc. | D- | — | $84.95 | — | $42.2M | -1,189.9% |
| ETRA | Electra Therapeutics, Inc. | 評価なし | — | $11.35 | — | — | — |
| FBRX | FORTE BIOSCIENCES, INC. | 評価なし | — | $76.99 | — | — | — |
| SLBT | SL Science Holding Limited | 評価なし | — | $1.83 | — | — | — |
| VCRE | Vicore Pharma Holding AB | 評価なし | — | $9.53 | — | — | — |
| VRXA | Veraxa Biotech Holding AG | 評価なし | — | $1.32 | — | — | — |
| VTVT | vTv Therapeutics Inc. | D- | — | $30.01 | — | $36.8M | -12.9% |
ファンダメンタルズは SEC 提出書類から、株価は直近の市場データ取得から。任意の列で並べ替えられます。数値がない企業はどちらの向きでも末尾になります。
時価総額の大きい順です。列をクリックすると並べ替えられます。数値がない企業はどちらの向きでも末尾になります。PER の欠落は割安ではなく赤字を意味するからです。ここに推奨は一切ありません。